Press Release
SoluLinK, Incorporated
9853
Pacific Heights Blvd. Suite H,
San Diego, California 92121
Phone: 858.625.0670
Fax: 858.625.0770
solulink@solulink.com
SoluLinK Receives Additional Investment from Plymouth Venture Partners
San Diego, California, January 10, 2008 -
SoluLinK, Inc., a leader in biomolecular conjugation products and kits in the multibillion dollar research assay and diagnostics markets, announced today it has received a second private placement funding from Plymouth Venture Partners (PVP) of Ann Arbor, Michigan.
With this additional funding, SoluLinK will continue its strategic plan to:
- Aggressively develop superior, faster, and simpler application specific products.
- Expand sales and marketing activities.
- Introduce components and kits whose unique and superior performance characteristics rely on the integration and utilization of the company’s proprietary conjugation technology.
“We are extremely pleased that Plymouth Venture Partners continues to share our vision for SoluLinK’s breakthrough conjugation products that move qualitative assay processes to quantitative ones for research, diagnostic, and drug discovery applications” said Steve DeGraw, President of SoluLinK. “This financing provides Solulink with the resources to vertically integrate its technology for greater market penetration into its research, diagnostic and pharmaceutical markets by expanding the pipeline of application specific products. The market has responded strongly to our first such application product, the ChromaLinkTM Biotin Labeling Kit. This first of its kind kit that biotinylates and quantifies the labeling of an antibody or protein with a single reagent.”
“With Plymouth’s initial investment, Solulink management exceeded our expectations in terms of product development and industry awareness. With this second funding, the company will establish a pipeline of new industry relevant assays and kits that take advantage of their built-in traceability, greater stability, higher performance, greater yields, process improvements and greater solubility,” said Mark Horne, CEO of Plymouth Venture Partners. “Solulink is a very promising company that we believe has the opportunity to define and lead this new field, and to develop products that achieve standards of consistency and efficiency unmet by current approaches.
About Plymouth Venture Partners
Plymouth Venture Partners (www.plymouthventurepartners.com) Plymouth Venture Partners I LLC (“PVP1”), based in Ann Arbor, has completed its third year of active private company investing. PVP1 was formed to bring together experienced investors for the purpose of screening, reviewing and funding investment opportunities in private companies. PVP1 invests in companies that have a proven ability to execute their business plans, strong management teams, credible exit plans, and strong and reliable sponsorship from professional investors.
About SoluLinK
SoluLinK is a leader in the development of conjuation reagents, kits and OEM services for the life sciences, diagnostic, and pharmaceutical communities. SoluLinK (a privately-held company located in San Diego, California) develops, manufactures, and markets bioconjugation products and services. SoluLink’s proprietary bioconjugation linking chemistry is used to link proteins, oligonucleotides, peptides, antibodies to each other or to a wide range of surfaces. Rapidly growing applications for SoluLink’s linking products include the conjugation of biomolecules for research assay, diagnostic and pharmaceutical products. SoluLinK’s proprietary biotinylation reagent ChromaLink® Biotin Labeling Kit is one example and the first of a pipeline of a new easy to use kits that is helping to enhance assay performance and measurement for similar customers in a broad range of large markets . SoluLinK markets these products both directly and through distributors and licensing partners world-wide.
For
more information, please contact Solulink directly:
SoluLinK - The Conjugation Company
9853 Pacific Heights Blvd. Suite H,
San Diego, California 92121
Toll Free: 888.625.0670
Phone: 858.625.0670
Fax: 858.625.0770
solulink@solulink.com |
